Buys Omnicare | Cvs

By late 2022, CVS began categorizing Omnicare as "no longer a strategic asset" due to financial losses and legal challenges.

CVS Health completed the acquisition of Omnicare in for a total enterprise value of approximately $12.9 billion . While the deal initially aimed to expand CVS's reach into long-term care and specialty pharmacy dispensing, recent developments as of April 2026 show that Omnicare is undergoing a court-supervised sale process. Key Acquisition Details (2015) cvs buys omnicare

: Approximately $12.9 billion, which included $10.4 billion in cash ($98 per share) and the assumption of $2.3 billion in debt. By late 2022, CVS began categorizing Omnicare as

: To provide CVS with a new dispensing channel for seniors and chronic care patients in assisted living and long-term care facilities. By late 2022